Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens

Código QR

Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens

Guardado en:

Detalles Bibliográficos
Autores principales:	Marc Lipsitch, Thomas V. Inglesby
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2014
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/d2f29d031fa64be4b06effbb948b2e60
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Erratum for Lipsitch and Inglesby, Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens
por: Marc Lipsitch, et al.
Publicado: (2015)

Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation
por: Thomas V. Inglesby, et al.
Publicado: (2020)

Rethinking Biosafety in Research on Potential Pandemic Pathogens
por: Marc Lipsitch, et al.
Publicado: (2012)

Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?
por: Marc Lipsitch
Publicado: (2014)

Reply to “Studies on Influenza Virus Transmission between Ferrets: the Public Health Risks Revisited”
por: Marc Lipsitch, et al.
Publicado: (2015)

The H5N1 Moratorium Controversy and Debate
por: Arturo Casadevall, et al.
Publicado: (2012)

Danger of Potential-Pandemic-Pathogen Research Enterprises
por: Lynn C. Klotz
Publicado: (2015)

Assessing and Managing the Risks of Potential Pandemic Pathogen Research
por: Daniel J. Rozell
Publicado: (2015)

An Epistemological Perspective on the Value of Gain-of-Function Experiments Involving Pathogens with Pandemic Potential
por: Arturo Casadevall, et al.
Publicado: (2014)

Reply to “Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?”
por: Arturo Casadevall, et al.
Publicado: (2014)

Does Pandemic A/H1N1 Virus Have the Potential To Become More Pathogenic?
por: Natalia A. Ilyushina, et al.
Publicado: (2010)

<italic toggle="yes">mBio</italic> Addresses the Pause in Gain-of-Function (GOF) Experiments Involving Pathogens with Pandemic Potential (PPP)
por: Arturo Casadevall, et al.
Publicado: (2014)

Vagueness and Costs of the Pause on Gain-of-Function (GOF) Experiments on Pathogens with Pandemic Potential, Including Influenza Virus
por: Michael J. Imperiale, et al.
Publicado: (2014)

Is the Debate and “Pause” on Experiments That Alter Pathogens with Pandemic Potential Influencing Future Plans of Graduate Students and Postdoctoral Fellows?
por: Julie K. Pfeiffer
Publicado: (2015)

Risks and Benefits of Gain-of-Function Experiments with Pathogens of Pandemic Potential, Such as Influenza Virus: a Call for a Science-Based Discussion
por: Arturo Casadevall, et al.
Publicado: (2014)

Ethical alternatives to experiments with novel potential pandemic pathogens.
por: Marc Lipsitch, et al.
Publicado: (2014)

A Systems Biology Approach to Infectious Disease Research: Innovating the Pathogen-Host Research Paradigm
por: Alan Aderem, et al.
Publicado: (2011)

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?
por: Marc Lipsitch, et al.
Publicado: (2016)

Predicting the Next Eye Pathogen: Analysis of a Novel Adenovirus
por: Christopher M. Robinson, et al.
Publicado: (2013)

Rapid Proliferation of Pandemic Research: Implications for Dual-Use Risks
por: Sriharshita Musunuri, et al.
Publicado: (2021)

The Pathogenic Potential of a Microbe
por: Arturo Casadevall
Publicado: (2017)

Pathogenicity of the Novel A/H7N9 Influenza Virus in Mice
por: Chris Ka Pun Mok, et al.
Publicado: (2013)

Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward
por: Anthony S. Fauci
Publicado: (2012)

A Novel Hybrid Iron Regulation Network Combines Features from Pathogenic and Nonpathogenic Yeasts
por: Franziska Gerwien, et al.
Publicado: (2016)

Is It Possible? A Different Approach to Creating a Universal Influenza Vaccine
por: Stacey Schultz-Cherry
Publicado: (2015)

Use of Highly Pathogenic Avian Influenza A(H5N1) Gain-Of-Function Studies for Molecular-Based Surveillance and Pandemic Preparedness
por: C. Todd Davis, et al.
Publicado: (2014)

A Novel Pathogenic Mammalian Orthoreovirus from Diarrheic Pigs and Swine Blood Meal in the United States
por: Athmaram Thimmasandra Narayanappa, et al.
Publicado: (2015)

H7N9 Avian Influenza A Virus and the Perpetual Challenge of Potential Human Pandemicity
por: David M. Morens, et al.
Publicado: (2013)

Novel Symbiotic Genome-Scale Model Reveals <i>Wolbachia</i> 's Arboviral Pathogen Blocking Mechanism in Aedes aegypti
por: Natalia E. Jiménez, et al.
Publicado: (2021)

Subversion of Lipopolysaccharide Signaling in Gingival Keratinocytes via MCPIP-1 Degradation as a Novel Pathogenic Strategy of Inflammophilic Pathobionts
por: Anna Gasiorek, et al.
Publicado: (2021)

Oral Epithelial Cells Distinguish between <i>Candida</i> Species with High or Low Pathogenic Potential through MicroRNA Regulation
por: Márton Horváth, et al.
Publicado: (2021)

Correction for Dietz et al., “2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission”
por: Leslie Dietz, et al.
Publicado: (2020)

Comparative Genomics of Recent Shiga Toxin-Producing <named-content content-type="genus-species">Escherichia coli</named-content> O104:H4: Short-Term Evolution of an Emerging Pathogen
por: Yonatan H. Grad, et al.
Publicado: (2013)

Pandemics and People
por: Michael J. Imperiale
Publicado: (2020)

Bacteriophages as Pathogens and Immune Modulators?
por: A. Lengeling, et al.
Publicado: (2013)

Precedence for the Role of Indole with Pathogens
por: Thomas K. Wood, et al.
Publicado: (2019)

Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential
por: Eveline Kindler, et al.
Publicado: (2013)

<named-content content-type="genus-species">Candida albicans</named-content> CUG Mistranslation Is a Mechanism To Create Cell Surface Variation
por: Isabel Miranda, et al.
Publicado: (2013)

Ancient-Pathogen Genomics: Coming of Age?
por: Adrian M. Whatmore
Publicado: (2014)

Evidence for an ABC-Type Riboflavin Transporter System in Pathogenic Spirochetes
por: Ranjit K. Deka, et al.
Publicado: (2013)